Helene Greigert
Overview
Explore the profile of Helene Greigert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greigert H, Bamde C, Ramon A, Steinmetz E, Bejot Y, Bouchot O, et al.
Joint Bone Spine
. 2025 Feb;
:105862.
PMID: 39984114
Apart from life-threatening and/or functional emergencies, treatment of vascular lesions in giant cell arteritis (GCA) is medical. Revascularization may be considered if the lesion remains symptomatic or progressive despite optimal...
2.
Thibault T, Alberini J, Billet A, Greigert H, Ramon A, Devilliers H, et al.
Front Med (Lausanne)
. 2024 Oct;
11:1469964.
PMID: 39469141
PET/CT is an imaging modality that is increasingly being used to diagnose large-vessel vasculitis. In the case of giant cell arteritis, it was first used to demonstrate inflammation of the...
3.
Ramon A, Greigert H, Goueslard K, Cladiere C, Ciudad M, Ornetti P, et al.
RMD Open
. 2024 Aug;
10(3).
PMID: 39122253
Introduction: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are frequently overlapping conditions. Unlike in GCA, vascular inflammation is absent in PMR. Therefore, serum biomarkers reflecting vascular remodelling could be...
4.
Billet A, Thibault T, Liozon E, de Boysson H, Perard L, Espitia O, et al.
Eur J Intern Med
. 2024 Apr;
126:69-76.
PMID: 38627183
Objectives: To evaluate the ability of FDG PET/CT, at diagnosis of giant cell arteritis (GCA) and during follow-up, to predict occurrence of relapse in large-vessel GCA (LV-GCA). Methods: We conducted...
5.
Guilhem A, Ciudad M, Aubriot-Lorton M, Greigert H, Cladiere C, Leguy-Seguin V, et al.
Front Immunol
. 2023 Dec;
14:1321182.
PMID: 38143764
Hereditary hemorrhagic telangiectasia (HHT) is a rare inherited disease due to heterozygous loss-of-function mutations on the BMP9/10 pathway ( or mainly). HHT endothelial cells are prone to lose their quiescence,...
6.
Maldiney T, Greigert H, Martin L, Benoit E, Creuzot-Garcher C, Gabrielle P, et al.
PLoS One
. 2023 Dec;
18(12):e0296315.
PMID: 38113232
[This corrects the article DOI: 10.1371/journal.pone.0234165.].
7.
Greigert H, Ramon A, Genet C, Cladiere C, Gerard C, Cuidad M, et al.
J Autoimmun
. 2023 Dec;
142:103151.
PMID: 38039746
Vascular smooth muscle cells (VSMCs) have been shown to play a role in the pathogenesis of giant cell arteritis (GCA) through their capacity to produce chemokines recruiting T cells and...
8.
Ciudad M, Ouandji S, Lamarthee B, Cladiere C, Ghesquiere T, Nivet M, et al.
Haematologica
. 2023 Aug;
109(2):444-457.
PMID: 37534543
Warm autoimmune hemolytic anemia (wAIHA) is a rare acquired autoimmune disease mediated by antibodies targeting red blood cells. The involvement of CD4 T-helper cells has been scarcely explored, with most...
9.
Zuily S, Lefevre B, Sanchez O, Empis de Vendin O, De Ciancio G, Arlet J, et al.
EClinicalMedicine
. 2023 Jun;
60:102031.
PMID: 37350990
Background: Venous thromboembolism is a major complication of coronavirus disease 2019 (COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation may decrease the risk of venous thromboembolism COVID-19 patients....
10.
Razanamahery J, Samson M, Guy J, Racine J, Row C, Greigert H, et al.
Haematologica
. 2023 Jun;
108(12):3444-3448.
PMID: 37317872
No abstract available.